ERα+ breast cancer cells (T47D) and non-TNBC cells (MDA-MB-231, BT549, Hs578T)
were seeded in 96-well plate at 50% confluency. On the next day, control siRNA or two YAP specific siRNA(YAP siRNA1, YAP siRNA2) were transfected into cells using RNAiMAX.
CCK8 was added to wells at time points of 24, 48 or 72 hours. 2 hours after incubation, absorbance at 450nm was measured to indicate cell number. The proliferation curves shown that YAP knockdown significantly inhibits both ERα+ breast cancer (A) and TNBC (B, C, D) cell proliferation. immunohistochemistry was applied to evaluate expression of YAP. YAP was overexpressed in both TNBC and ERα+ breast cancer patients.
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